P1.15-03. Clinical Outcomes Among Patients With Non-small Cell Lung Cancer Who Discontinued Immune Checkpoint Inhibitors Due to Toxicity
Back to course
Pdf Summary
Asset Subtitle
Federica Pecci, United States
Meta Tag
Speaker Federica Pecci, United States
Topic Metastatic Non-small Cell Lung Cancer – Immunotherapy
non-small cell lung cancer
immune checkpoint inhibitors
immune-related adverse events
clinicopathologic characteristics
patient outcomes
discontinued treatment
corticosteroid use
PD-L1 expression
post-discontinuation progression-free survival
Powered By